Skip to main content
logo
Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.670
-0.080 (-2.13%)
At close: Jul 8, 2026, 4:00 PM EDT
3.628
-0.042 (-1.15%)
After-hours: Jul 8, 2026, 5:03 PM EDT

Editas Medicine Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
38.6940.5232.3178.1219.7125.54
Revenue Growth (YoY)
7.97%25.39%-58.64%296.32%-22.83%-71.85%
Gross Profit
38.6940.5232.3178.1219.7125.54
Selling, General & Admin
46.7649.971.9969.6570.776.18
Research & Development
80.9689.95199.25177.65174.96142.51
Other Operating Expenses
19.8260.6712.23---
Total Operating Expenses
147.54200.53283.47247.3245.66218.69
Operating Income
-108.85-160.01-251.15-169.18-225.95-193.15
Interest Income
6.88.3116.2517.575.520.61
Interest Expense
-5.03-6.17-2.19---
Other Non-Operating Income (Expense)
-1.88-2.19-0-1.6-0.04
Total Non-Operating Income (Expense)
-0.1-0.0514.0615.965.520.64
Pretax Income
-108.95-160.06-237.09-153.22-220.43-192.5
Net Income
-108.95-160.06-237.09-153.22-220.43-192.5
Net Income to Common
-108.95-160.06-237.09-153.22-220.43-192.5
Shares Outstanding (Basic)
928982766968
Shares Outstanding (Diluted)
928982766968
Shares Change (YoY)
11.85%7.78%8.39%10.63%1.55%15.37%
EPS (Basic)
-1.23-1.80-2.88-2.02-3.21-2.85
EPS (Diluted)
-1.23-1.80-2.88-2.02-3.21-2.85
Free Cash Flow
-141.09-165.85-219.11-136.9-181.47-171.78
Free Cash Flow Per Share
-1.53-1.87-2.66-1.80-2.64-2.54
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-281.32%-394.89%-777.22%-216.56%-1146.26%-756.13%
Profit Margin
-281.59%-395.01%-733.72%-196.13%-1118.26%-753.61%
FCF Margin
-364.63%-409.30%-678.06%-175.23%-920.59%-672.49%
EBITDA
-105.01-154.73-245.34-163.12-219.61-188.09
EBITDA Margin
-271.38%-381.87%-759.25%-208.80%-1114.11%-736.35%
EBIT
-108.85-160.01-251.15-169.18-225.95-193.15
EBIT Margin
-281.32%-394.89%-777.22%-216.56%-1146.26%-756.13%
SEC Filings: 10-K · 10-Q